Too many initiatives in the European Union are blunted by lack of clarity. That can’t happen with cluster policy, says the Science|Business Innovation Board.
Cambridge, Mass., is acknowledged as one of the leading biotech clusters. The question now: how to maintain that edge in the face of global competition.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.